Team:Queens Canada/Safety/FAQs
From 2011.igem.org
Line 123: | Line 123: | ||
Our biobricks are considered safe. Many of our parts are naturally occurring genetic sequences in C. elegans and thus cannot be classified as transgenic. Our transgenic components are GPCRs taken from higher eukaryotic organisms such as mice and humans. None of our parts are known to produce toxic or infective effects. | Our biobricks are considered safe. Many of our parts are naturally occurring genetic sequences in C. elegans and thus cannot be classified as transgenic. Our transgenic components are GPCRs taken from higher eukaryotic organisms such as mice and humans. None of our parts are known to produce toxic or infective effects. | ||
</regulartext> | </regulartext> | ||
+ | |||
+ | <div id="goright"> | ||
+ | <span class="classgreen"><a href="https://2011.igem.org/Team:Queens_Canada/Intro/Team#top">back to top</a><span> | ||
+ | </div> | ||
+ | |||
</div> | </div> | ||
Line 156: | Line 161: | ||
Canada does have national biosafety regulations. They can be found <span class="classredt"><a href="http://www.phac-aspc.gc.ca/lab-bio/res/blk-acb/lbg-ldmbl-eng.php">here</a><span>. <p> | Canada does have national biosafety regulations. They can be found <span class="classredt"><a href="http://www.phac-aspc.gc.ca/lab-bio/res/blk-acb/lbg-ldmbl-eng.php">here</a><span>. <p> | ||
</regulartext> | </regulartext> | ||
+ | <div id="goright"> | ||
+ | <span class="classgreen"><a href="https://2011.igem.org/Team:Queens_Canada/Intro/Team#top">back to top</a><span> | ||
+ | </div> | ||
+ | |||
</div> | </div> | ||
Line 170: | Line 179: | ||
<regulartext> As a new direction in Human Practices, the Queen’s team is creating a series of recommendations on how the Canadian Security Intelligence Service (CSIS) could deal with bioterrorism informed by synthetic biology. </regulartext> | <regulartext> As a new direction in Human Practices, the Queen’s team is creating a series of recommendations on how the Canadian Security Intelligence Service (CSIS) could deal with bioterrorism informed by synthetic biology. </regulartext> | ||
+ | |||
+ | <div id="goright"> | ||
+ | <span class="classgreen"><a href="https://2011.igem.org/Team:Queens_Canada/Intro/Team#top">back to top</a><span> | ||
</div> | </div> | ||
+ | |||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
</html> | </html> |
Revision as of 06:12, 28 September 2011
a. Risks to the safety and health of team members or others in the lab?
b. Risks to the safety and health of the general public if released by
design or accident?
c. Risks to environmental quality if released by design or accident?
d. Risks to security through malicious misuse by individuals, groups or states?
a. Pathogenicity, infectivity, or toxicity?
b. Threats to environmental quality?
c. Security concerns?
a. Does your institution have its own bio-safety rules and if so what are they?
b. Does your institution have an Institutional Biosafety Committee or
equivalent group? If yes, have you discussed your project with them?
c. Will / did you receive any biosafety and/or lab training before
beginning your project? If so, describe this training.
d. Does your country have national biosafety regulations or
guidelines?
a. How could parts, devices and systems be made even safer through biosafety engineering?